Southern Public Company Limited (“the Company”) would like to submit the Management Discussion and Analysis for the third quarter ended September 30, 2020 as follows: Operating performance overview for the
Company”) would like to summarize its Q3/2019 operating performance for the period ending 30 September 2019 as follows: For the three-month, the Company and its subsidiaries’ posted a net profit of Baht
Stock Exchange of Thailand Ekachai Medical Care Public Company Limited (the “Company”) would like to clarify on the operating results for the Third quarter of 2019 at the end of 30th September 2019 as
, the Company and its subsidiaries generated cash flows from operating activities of approximately THB 2,053.93 million, increased by THB 8.22 million from the same period last year. GFPT Public Company
from the Company’s profit 45.6 MB and profit from operation 92.8 MB of this year. Cash Flow Based on the results for Q3/2019, the company’s cash flow is as follows: - Net cash flows from operating
Refined Glycerine Vessel operating Total Sale and service Other income Total revenues Revenues from sales and services 1,820.91 0.00 16.22 4.88 1,842.01 1.55 1,843.56 Cost of sales and services (1,640.05
Glycerine Vessel operating Total Sale and service Other income Total revenues Revenues from sales and services 993.67 0.00 43.04 4.90 1,041.61 1.48 1,043.09 Cost of sales and services (954.63) 0.00 (40.15
net loss of 2.29 million Baht in the 1st quarter of 2020, comparing increased loss by 1.98 million Baht from the continued operating losses. At present, the subsidiary (AIPT) has temporarily ceased its
/ Registered Capital / Fees | - |- Licensing (Section 90) | - |- Activities NOT deem TO be classified AS operating securities business | - |- Registered Capital (Section 96) | - |- Revocation of License (Section